The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells. [electronic resource]
Producer: 20041221Description: 3156-64 p. digitalISSN:- 0014-2980
- Antineoplastic Agents -- pharmacology
- Apoptosis -- physiology
- Apoptosis Regulatory Proteins
- Bcl-2-Like Protein 11
- Carrier Proteins -- antagonists & inhibitors
- Cell Line, Tumor
- Cell Survival -- physiology
- Cycloheximide -- pharmacology
- Dactinomycin -- pharmacology
- Humans
- Interleukin-6 -- immunology
- Janus Kinase 2
- Membrane Proteins -- antagonists & inhibitors
- Multiple Myeloma -- immunology
- Myeloid Cell Leukemia Sequence 1 Protein
- Neoplasm Proteins -- antagonists & inhibitors
- Protein Isoforms
- Protein Synthesis Inhibitors -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- Transcription, Genetic -- immunology
- Tyrphostins -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.